既往剖宫产患者早孕期经阴道超声筛查剖宫产瘢痕妊娠的证据分析
本文为意见文章,系统应用Wilson和Jungner的10条经典筛查标准,评估剖宫产瘢痕妊娠是否满足筛查试验要求,并分析在既往剖宫产患者中于早孕期开展经阴道超声筛查的可行性与现实性。文章认为剖宫产瘢痕妊娠是晚孕期胎盘植入谱系的早期前驱病变,应在早孕期诊断,可通过在既往剖宫产患者妊娠中引入规范化超声筛查实现。
要点
- 剖宫产瘢痕妊娠是第二、三孕期胎盘植入谱系的早期前驱病变,应在早孕期诊断。
- 对既往剖宫产患者妊娠引入规范化超声筛查,可能实现剖宫产瘢痕妊娠的早孕期诊断。
- 文章按Wilson和Jungner的10条经典筛查标准逐条评估剖宫产瘢痕妊娠筛查的可行性。
核心结论
- 剖宫产瘢痕妊娠是第二、三孕期胎盘植入谱系的早期前驱病变,应在早孕期诊断,可通过在既往剖宫产患者妊娠中引入规范化超声筛查实现。
研究设计与样本
- 本文为意见文章,系统应用Wilson和Jungner的10条经典筛查标准评估剖宫产瘢痕妊娠是否满足筛查试验要求。
主要发现
- 文章认为剖宫产瘢痕妊娠是第二、三孕期胎盘植入谱系的早期前驱病变。
关键数值与推荐
- 文章将Wilson和Jungner的10条经典筛查标准逐条应用于剖宫产瘢痕妊娠,以评估其是否满足筛查要求。
临床怎么用
- 文章提出应在早孕期诊断剖宫产瘢痕妊娠,并可通过在既往剖宫产患者妊娠中引入规范化超声筛查来实现。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Obstetric hemorrhage is a leading cause of maternal morbidity and mortality. An important etiology of obstetric hemorrhage is placenta accreta spectrum. In the last 2 decades, there has been increased clinical experience of the devastating effect of undiagnosed, as well as late diagnosed, cases of cesarean scar pregnancy. There is a growing body of evidence suggesting that cesarean scar pregnancy is an early precursor of second- and third-trimester placenta accreta spectrum. As such, cesarean scar pregnancy should be diagnosed in the early first trimester. This early diagnosis could be achieved by introducing regimented sonographic screening in pregnancies of patients with previous cesarean delivery. This opinion article evaluates the scientific and clinical basis of whether cesarean scar pregnancy, with special focus on its early first-trimester discovery, complies with the accepted requirements of a screening test. Each of the 10 classical screening criteria of Wilson and Jungner were systematically applied to evaluate if the criteria were met by cesarean scar pregnancy, to analyze if it is possible and realistic to carry out screening in a population-wide fashion.
引用
- Timor-Tritsch IE, Monteagudo A, Goldstein SR, et al. Early first-trimester transvaginal ultrasound screening for cesarean scar pregnancy in patients with previous cesarean delivery: analysis of the evidence. Am J Obstet Gynecol. 2024. PMID: 38955324. doi:10.1016/j.ajog.2024.06.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。